ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,265 | -11.8% | 6,900 | +33.5% | 0.00% | 0.0% |
| Q2 2023 | $53,603 | +28.2% | 5,169 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $41,817 | -51.2% | 5,169 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $85,754 | +20.8% | 5,169 | +13.9% | 0.00% | 0.0% |
| Q3 2022 | $71,000 | +12.7% | 4,539 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $63,000 | -8.7% | 4,539 | +14.1% | 0.00% | +50.0% |
| Q1 2022 | $69,000 | +19.0% | 3,979 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $58,000 | -19.4% | 3,979 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $72,000 | +20.0% | 3,979 | +16.9% | 0.00% | +50.0% |
| Q2 2021 | $60,000 | +2900.0% | 3,404 | +52.1% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 2,238 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 2,238 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -60.0% | 2,238 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -61.5% | 2,238 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $13,000 | -23.5% | 2,238 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $17,000 | -46.9% | 2,238 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $32,000 | -28.9% | 2,238 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $45,000 | +45.2% | 2,238 | +26.5% | 0.00% | +100.0% |
| Q1 2018 | $31,000 | -29.5% | 1,769 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $44,000 | -2.2% | 1,769 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $45,000 | -6.2% | 1,769 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $48,000 | +128.6% | 1,769 | +152.0% | 0.00% | +100.0% |
| Q1 2017 | $21,000 | – | 702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |